REVOLADE eltrombopag 12.5mg film-coated tablet blister pack

Approval Id: 628710f2a8d278a0
Product Name: REVOLADE eltrombopag 12.5mg film-coated tablet blister pack
Artg Id: 236115
Artg Name: REVOLADE eltrombopag 12.5mg film-coated tablet blister pack
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2016-03-30
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: https://medical-cdn.nocode.com/drug_tga/f51291b870ac09c1fb957f1b7f471d63.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

628710f2a8d278a0

Type

Standard